While research is still limited, rapid weight loss can also create emotional changes
Doubling up or taking doses too close together does not "make up" for the missed dose
A meta-analysis covering over 28,000 patients found that while the overall rate of GI adverse events was similar (approximately 5253% of patients in both groups), serious adverse events occurred somewhat more frequently with higher tirzepatide doses (5.37% at 1015 mg) compared to semaglutide (2.8%)
These additions do not accelerate semaglutide onset but may provide additional benefits like energy support or improved tolerability
After its expiration date, the medication may not work as well for weight loss, weight maintenance, or blood sugar control
The study comes from a single large health system in Ohio and Florida, which limits how broadly the findings can be applied across different demographics and care settings